|
12/28/2021 12:00 AM EST
A federal court permanently enjoined a New Jersey entity and its principals from distributing unapproved and misbranded drugs touted as a treatment for COVID-19.
|
Manage your Subscriptions | Department of Justice Privacy Policy | GovDelivery Privacy Policy
DEALS ENTER TO WIN SHOP NOW ...
No comments:
Post a Comment